Background: Obesity is a common health problem around the world. Studies have shown inverse relationship between serum vitamin D levels with obesity among patients and healthy population. The aim of this present study is to examine the relationship between serum vitamin D levels with general and abdominal obesity among migraine patients.
INTRODUCTION
Obesity has been considered as a general health problem around the world. [1] In the United States, the prevalence of obesity is 35.5% among men and 35.8% among women [2] and in Iran it has been reported 42.9% among men and 56.9% among women. [1] Obesity is related to increased risk of hyper-tension, diabetes mellitus, cardiovascular disease, arthritis, gallbladder disease, and cancer. [1] Furthermore, recent studies have shown a possible relationship between migraine and obesity. [3, 4] Obesity is associated with greater frequency and severity of migraine. [3] Mechanisms of physiological, psychological and behavioral are involved in the relationship between obesity and migraine. [3] Vitamin D deficiency has been determined as a public-health issue. [5] The prevalence of vitamin D deficiency is 30-80% among children and adult world-wide. [6] In Iran, prevalence of vitamin D deficiency has been observed 72.1% in men and 75.1% in women. [7] In Isfahan, 19.6%, 23.9% and 26.9 of people have mild, moderate, and severe vitamin D deficiency, respectively. [8] Vitamin D deficiency is related to musculoskeletal disorders, cancer, autoimmune disorders, cardiovascular disorders, kidney disorders, mental disorders, and skin disorders. [9] Evidence have determined an inverse relationship between vitamin D levels with headache. [5, [9] [10] [11] [12] [13] [14] [15] Number of studies have found that serum vitamin D levels are associated with obesity among population health and patients. [16] [17] [18] [19] [20] [21] [22] [23] However, in some other studies, the relationship was not seen. [24, 25] Thus, the present study was conducted to investigate the association between serum levels of vitamin D with general and abdominal obesity among patients with migraine.
METHODS
Participants This is a cross-sectional study that was performed among 66 migraine patients aged 19-61 years in Isfahan city, Iran, in autumn 2012. Informed consent was taken from all participants.
Anthropometric measurement and other information's
At baseline, age, gender, weight, height, waist circumference (WC), body mass index (BMI), education level, medical history, the use of vitamin and mineral supplements were gathered. Weight was determined (within 0.5 kg) using analog scale in light clothes and without shoes. Height was determined (within 0.5 cm) with tape measure without shoes. General obesity was assessed using BMI. Overweight and obesity was defined as BMI ≥ 25 and BMI ≥ 30, respectively. BMI was obtained through weight (kilogram) divided into height (meter squared). BMI category was determined as: Lean (values <18.5); normal weight (values 18.5-24.9); overweight (values 25-29.9) and obesity (values ≥ 30). Abdominal obesity was assessed by WC. Central obesity was determined as WC ≥ 88 for women and WC ≥ 102 for men. [1] WC were taken (within 0.5 cm) using inelastic tape at the narrowest part of body, under the ribs.
Biochemical measurement
Serum 25-OH-D3 was measured to evaluate serum vitamin D levels using enzyme-linked immunosorbent assay. Serum vitamin D levels were categorized as: Vitamin D deficiency (values less than 12 ng/ml); vitamin D insufficiency (values between 12 ng/ml and 30 ng/ml), and vitamin D sufficiency (values more than 30 ng/ml). Calcium, phosphor, and albumin measurements were conducted for the diagnosis of primary hyperparathyroidism.
Statistical analysis
Statistical analysis was performed by the SPSS 18.0 software. Partial correlation was conducted to survey the association between serum levels of vitamin D with general and abdominal obesity. Significance levels were determined as P < 0.05.
RESULTS
In this study, 66 migraine patients with mean age of 35.9 ± 9.01 years were included for analysis. Patients with diabetes mellitus, metabolic syndrome, cardiovascular diseases and hypertension, and liver diseases were excluded. There were 49 women with mean age of 35.7 ± years and 17 men with mean age of 36.6 ± 10.2 years. Table 1 shows demographical characteristics of patients. Mean BMI was higher among female. However, mean WC was higher among male. Deficiency, insufficiency, and sufficiency of vitamin D were observed 13.6%, 66.7%, and 19.7% among migraine patients, respectively. 51.5% and 18.2% of adults had overweight and obesity, respectively. Table 2 shows serum vitamin D status among women and men. 77.6% of women and 88.2% of men have serum vitamin D levels less than 30. There was no differences between serum levels of albumin, calcium, and phosphorus among different vitamin D groups. Partial correlation was used to investigate the association between serum levels of vitamin D with BMI and WC. Table 4 shows the relationship between vitamin D with BMI and WC among patients with migraine. According to Table 4, significant association was not found between serum 25-OH-D levels with WC (P = 0.83) and BMI (P = 0.92). In www.mui.ac.ir this analysis, confounding variables such as sex, age, and education were adjusted. However, a significant positive relationship was determined between BMI and WC.
DISCUSSION
Results of the present study showed that serum levels of vitamin D are not related to WC and BMI. However, a significant inverse relationship was observed between BMI and WC among patients with migraine.
Most studies have shown an inverse relationship between serum levels of vitamin D and general obesity among population health and patients. [16] [17] [18] [19] [20] [21] [22] [23] However, in some other studies, the association was not found. [24, 25] Furthermore, some studies have shown inverse relationship between serum vitamin D levels with WC, [21, 22, 25, 26] but in some other studies the relationship was not observed. [27] In a cross-sectional study conducted on obese or overweight patients, vitamin D status was associated with the degree of obesity, especially, in patients with BMI more than 40.Patients with vitamin deficiency had higher BMI and WC and the relationship between vitamin D with metabolic syndrome was not dependent to the degree of obesity. [26] In another study, inverse association was found between serum vitamin D (25-OH-D3 and 1,25-(OH)2-D3) with BMI. Prevalence of vitamin D deficiency was the highest among patients with BMI more than or equal to 40. This results shows one out of every three female and one out of every two male with BMI more than or equal to 40 have vitamin D deficiency. [17] In Kuala Lumpur, a study by Khor et al. was performed among children aged 7-12 years. Only in boys, inverse relationship was observed between BMI for age with vitamin D status. [28] A study conducted among cancer patients, showed that obese patients have lower vitamin D levels compared with normal weight and overweight individuals. After adjustments for age, a unit increase in BMI was significantly related to reduced 0.42 ng/ml in serum levels of 25-OH-D3. [23] Another study, was carried out in Mashhad in rheumatoid patients. Inverse correlation was determined between BMI with serum vitamin D levels. However, when they were divided into three groups based on vitamin D status, patients with serum levels of vitamin D more than 35 nmol/l had significantly lower BMI compared to serum levels of vitamin D less than 25 nmol/l. [29] Vilarrasa et al. observed inverse correlation between serum vitamin D levels with weight, BMI, waist to hip ratio, body fat, fat mass and fat free mass. However, after adjustment for confounder variables, only relationship was seen between serum vitamin D with body fat. [30] In another study, higher levels of 25-OH-D3 was inversely associated with BMI, hip circumference and total body fat (TBF) among women not men. However, after adjustments Data have been shown as number and percent [25] It looks obese people require higher doses of vitamin D compared with lean people to reach the same levels of vitamin D. [31] In a study, increase in serum vitamin Dafter a year, was significantly and inversely related to BMI at baseline. [31] Similarly, Saliba et al., investigated the association between obesity and increase in serum vitamin D after consumption of vitamin D supplementation. Inverse relationship was observed between serum vitamin D levels and BMI. However, after consumption of vitamin D, increase in the serum vitamin D levels were more obvious at the lower primary levels among individuals with normal weight compared to obese people. [32] Measurement of 25-OH-D and 1,25-(OH) 2 -dare valuable among obese people. [16] In Norway, the relationship between serum levels of 25-OH-D and 1,25(OH) 2 D with body composition was assessed among obese patients. 1,25(OH) 2 D concentrations was 25.4 pmol/l lower in lowest quartile compared to highest quartile of 25-OH-D. A unit increase in BMI was associated with decreased 1 nmol/l in 25-OH-D and decreased 0.9 pmol/l in 1, 25-(OH) 2 -D. [16] In this regard, several hypothesis and mechanisms have been determined for relationship between serum vitamin D levels with obesity. First, obese people are less exposed to sun light. [26] Second, obese patients have inadequate intakes of vitamin D. [26] Third, reduced bioavailability of vitamin D among obese patients. [26] Forth, vitamin D is fat-soluble that is mainly sequestered in adipose tissue, [25, 33] thus, is low in serum levels of obese patients. [25] This study has several limitations. First, the current study is cross-sectional, for this reason we cannot determine a causal link, therefore, clinical trial studies are essential to conduct. Second, the sample size of this study is small and more studies are needed to perform with greater sample size. Third, more adjustments for confounding variables such as physical activity and sun exposure must be performed.
CONCLUSIONS
In summary, no association was observed between serum vitamin D levels with BMI and WC among migraine patients. Therefore, more studies are required to conduct with larger sample size.
